1-8 of 8
Jay Friedman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A13: Neoadjuvant PD-1 mAb treatment induces postoperative immune memory responses against both immunodominant and immunorecessive antigens

Clint T. Allen, Jay Friedman, Paul Zolkind, Ravindra Uppaluri
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): A13.
https://doi.org/10.1158/1557-3265.AACRAHNS19-A13
Published: 15 June 2020
View article titled, Abstract A13: Neoadjuvant PD-1 mAb treatment induces postoperative immune memory responses against both immunodominant and immunorecessive antigens
Journal Articles

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt, Jay Friedman, Lucas A. Horn, Claudia Palena, Jeffrey Schlom, Dean Y. Maeda, John A. Zebala, Paul E. Clavijo, Clint Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1420–1431.
https://doi.org/10.1158/1078-0432.CCR-19-2625
Published: 13 March 2020
View article titled, Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Open the PDF for Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

Jay Friedman, Ellen C. Moore, Paul Zolkind, Yvette Robbins, Paul E. Clavijo, Lilian Sun, Sarah Greene, Megan V. Morisada, Wojciech K. Mydlarz, Nicole Schmitt, James W. Hodge, Hans Schreiber, Carter Van Waes, Ravindra Uppaluri, Clint Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 679–689.
https://doi.org/10.1158/1078-0432.CCR-19-2209
Published: 03 February 2020
View article titled, Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells
Open the PDF for Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells in another window
Includes: Supplementary data
Journal Articles

Abstract PR06: The effect of low-dose fractionated versus high-dose hypofractionated radiotherapy on antitumor immunity

Megan V. Morisada, Ellen C. Moore, Jay Friedman, Clint T. Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): PR06.
https://doi.org/10.1158/1557-3265.AACRAHNS17-PR06
Published: 30 November 2017
View article titled, Abstract PR06: The effect of low-dose fractionated versus high-dose hypofractionated radiotherapy on antitumor immunity
Journal Articles

Abstract 34: Wee1 inhibition sensitizes tumor cells with variable antigenicity to T cell mediated lysis

Ellen Moore, Lillian Sun, Jay Friedman, Carter Van Waes, Clint Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 34.
https://doi.org/10.1158/1557-3265.AACRAHNS17-34
Published: 30 November 2017
View article titled, Abstract 34: Wee1 inhibition sensitizes tumor cells with variable antigenicity to T cell mediated lysis
Journal Articles

Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

Francisco G. Pernas, Clint T. Allen, Mary E. Winters, Bin Yan, Jay Friedman, Bhavana Dabir, Kunal Saigal, Gerhard S. Mundinger, Xiaojiang Xu, John C. Morris, Katherine R. Calvo, Carter Van Waes, Zhong Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2361–2372.
https://doi.org/10.1158/1078-0432.CCR-08-1011
Published: 01 April 2009
View article titled, Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer
Open the PDF for Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer

Jay Friedman, Liesl Nottingham, Praveen Duggal, Francisco G. Pernas, Bin Yan, Xin Ping Yang, Zhong Chen, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6568–6578.
https://doi.org/10.1158/1078-0432.CCR-07-1591
Published: 15 November 2007
View article titled, Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer
Open the PDF for Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status

Tin Lap Lee, Xin Ping Yang, Bin Yan, Jay Friedman, Praveen Duggal, Lorena Bagain, Gang Dong, Ning T. Yeh, Jie Wang, Jian Zhou, Abdel Elkahloun, Carter Van Waes, Zhong Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5680–5691.
https://doi.org/10.1158/1078-0432.CCR-07-0670
Published: 01 October 2007
View article titled, A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status
Open the PDF for A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status in another window
Includes: Supplementary data